Edwards Lifesciences's total assets for Q3 2025 were $13.27B, a decrease of -1.61% from the previous quarter. CH:EW total liabilities were $3.07B for the fiscal quarter, a 6.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.